Cargando…
Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939310/ https://www.ncbi.nlm.nih.gov/pubmed/36815052 http://dx.doi.org/10.1016/j.apsb.2022.10.012 |
| _version_ | 1784890818795929600 |
|---|---|
| author | Wang, Guan Wu, Yongya Wu, Chengyong Shuai, Wen Jiang, Tingting Wang, Aoxue Bu, Faqian Sun, Qiu Ouyang, Liang |
| author_facet | Wang, Guan Wu, Yongya Wu, Chengyong Shuai, Wen Jiang, Tingting Wang, Aoxue Bu, Faqian Sun, Qiu Ouyang, Liang |
| author_sort | Wang, Guan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9939310 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99393102023-02-21 Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy Wang, Guan Wu, Yongya Wu, Chengyong Shuai, Wen Jiang, Tingting Wang, Aoxue Bu, Faqian Sun, Qiu Ouyang, Liang Acta Pharm Sin B Letter to the Editor Elsevier 2023-01 2022-10-19 /pmc/articles/PMC9939310/ /pubmed/36815052 http://dx.doi.org/10.1016/j.apsb.2022.10.012 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Wang, Guan Wu, Yongya Wu, Chengyong Shuai, Wen Jiang, Tingting Wang, Aoxue Bu, Faqian Sun, Qiu Ouyang, Liang Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy |
| title | Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy |
| title_full | Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy |
| title_fullStr | Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy |
| title_full_unstemmed | Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy |
| title_short | Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy |
| title_sort | rational design and crystallographic analysis of novel isoform-selective trka inhibitors for cancer therapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939310/ https://www.ncbi.nlm.nih.gov/pubmed/36815052 http://dx.doi.org/10.1016/j.apsb.2022.10.012 |
| work_keys_str_mv | AT wangguan rationaldesignandcrystallographicanalysisofnovelisoformselectivetrkainhibitorsforcancertherapy AT wuyongya rationaldesignandcrystallographicanalysisofnovelisoformselectivetrkainhibitorsforcancertherapy AT wuchengyong rationaldesignandcrystallographicanalysisofnovelisoformselectivetrkainhibitorsforcancertherapy AT shuaiwen rationaldesignandcrystallographicanalysisofnovelisoformselectivetrkainhibitorsforcancertherapy AT jiangtingting rationaldesignandcrystallographicanalysisofnovelisoformselectivetrkainhibitorsforcancertherapy AT wangaoxue rationaldesignandcrystallographicanalysisofnovelisoformselectivetrkainhibitorsforcancertherapy AT bufaqian rationaldesignandcrystallographicanalysisofnovelisoformselectivetrkainhibitorsforcancertherapy AT sunqiu rationaldesignandcrystallographicanalysisofnovelisoformselectivetrkainhibitorsforcancertherapy AT ouyangliang rationaldesignandcrystallographicanalysisofnovelisoformselectivetrkainhibitorsforcancertherapy |